Genetics of pre-eclampsia

Hypertension in Pregnancy

Volumn 12, Issue 1, 1993, Pages 1-23

  Cooper, Desmond W ^a   Brennecke, Shaun P ^b   Wilton, Alan N ^c  

^a MACQUARIE UNIVERSITY   (Australia)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; FEMALE; HUMAN; HYPERTENSION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW;

EID: 0027241658     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959309031050     Document Type: Article

References (89)

1. Animal models of pre-eclampsia
2. Genetics and immunology in the aetiology of severe pre-eclampsia
3. Inheritance and family patterns in pre-eclampsia and eclampsia
4. Hypertension in pregnancy
5. Preeclampsia: pathophysiology, diagnosis, and management
6. Revised definition of pre-eclampsia
7. A clinical study of pre-eclampsia. Part I
8. Long-term effect of pre-eclampsia on blood pressure
9. Hypertension in pregnancy: clinical-pathological correlations and remote prognosis
10. Immunologic aspects of pre-eclampsia
11. Immunological aspects of preeclampsia/eclampsia
12. The role of the spiral arteries in the pathogenesis of pre-eclampsia
13. The ultrastructure of acute atherosis in hypertensive pregnancy
14. Pre-eclampsia is associated with a serum factor cytotoxic to human endothelial cells
15. Lipid peroxidation in pregnancy: new perspectives on preeclampsia
16. Preeclampsia: an endothelial cell disorder
17. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production
18. Plasma endothelin-1 levels in patients with pregnancy-induced hypertension
19. Vascular responsiveness to pressor agents during human pregnancy
20. Hemodynamics in hypertensive pregnancy
21. Pre-eclampsia in pregnancies from donor inseminations
22. Oocyte donation in 61 patients
23. Pre-eclampsia and trisomy 13: a possible association
24. Pre-eclampsia and trisomy 13
25. Congenital idopathic adrenal hypoplasia
26. National Health and Medical Research Council Report on Maternal Deaths in Australia 1982-84
27. The familial factor in toxemia of pregnancy
28. Pregnancy in the sisters and daughters of eclamptic women
29. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women
30. Genetic control of severe pre-eclampsia
31. The incidence of severe pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls
32. Familial aspects of pre-eclampsia and hypertension in pregnancy
33. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population
34. Genetic control of susceptibility to eclampsia and miscarriage
35. Association between susceptibility to pre-eclampsia within families and HLA DR4
36. Some aspects of first births and heights of twin sisters of known zygosity
37. Pre-eclampsia: discordance among identical twins
38. On the familial appearances of maternal and foetal incompatibility
39. Genetical antigenic incompatibility as a possible cause of the toxaemias occurring late in pregnancy
40. Androgenetic origin of hydatidiform mole
41. Pre-eclampsia in pregnancies by different fathers: immunological studies
42. Pre-eclampsia/eclampsia: a fatal father factor
43. Evidence of a mitochondrial DNA-mutation in a family with a high occurrence of preeclampsia/eclampsia
44. Nomenclature factors of the HLA system 1990
45. Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLA DRB
46. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule
47. Class I antigen, HLA-G, expressed in human trophoblasts
48. Low-dose aspirin in prevention of toxaemia of pregnancy. Does it have a place?
49. Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies
50. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction
51. Human DNA polymorphisms and methods of analysis
52. Aspects of pre-eclamptic toxaemia of pregnancy, consanguinity, and twinning in Ankara
53. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy
54. The incidence of pregnancy induced hypertension in southeast Turkey
55. International survey of eclampsia and pre-eclampsia, 1958-1959. Epidemiologic aspects
56. Incidence and relation to parity of pregnancy induced hypertension in Iceland
57. An epidemiological study of the immunogenetic aetiology of pre-eclampsia
58. Preeclampsia in twin pregnancy – severity and pathogenesis
59. Immunogenetic factors in preeclampsia and eclampsia
60. Human leucocyte antigens and mixed lymphocyte reaction in severe pre-eclampsia
61. HLA antigens in severe preeclampsia
62. HLA A, B, and DR antigens in preeclampsia: preliminary results
63. Histocompatibility antigens, mixed lymphocyte reactivity and severe preeclampsia in Israel
64. HLA antigens-antibodies system and its association with severe toxemia of pregnancy
65. Immunogenetic aspects of preeclampsia
66. Histocompatibility studies in preeclampsia
67. Association of HLA DR4 with the risk of recurrence of pregnancy hypertension
68. [Increase in the frequency of HLA DR4 antigens in recurrent arterial hypertension of pregnancy.] Augmentation de la frequence de l'antigene HLA DR4 dans l'hypertension recidivante de la grossesse
69. Human leucocyte antigen status in African women with eclampsia
70. Genetic control of susceptibility to eclampsia and miscarriage
71. HLA status of the fetus born to African women with eclampsia
72. Pre-eclampsia is associated with HLA-DR4 sharing between mother and fetus
73. HLA-DR and pre-eclampsia in Edinburgh
74. Association between risk for pre-eclampsia and HLA DR4
75. HLA DRB types in pre-eclampsia and eclampsia
76. Pre-eclampsia and HLA-DR4
77. [HLA antigens in late pregnancy toxicosis]
78. [Study of compatibility in married couples according to the HLA system in normal and complicated by late toxemia pregnancy] Izuchenie sovmestimosti supruzheshakh par po antigenam sistemy HLA pri normal'no protekaiushchei i oslozhnennoi pozdnim toksik ozom beremennosti
79. Severe pre-eclampsia/eclampsia maternal susceptibility genes are not closely linked to HLA
80. Absence of close linkage between pre-eclampsia/eclampsia and immunoglobulin G heavy chains (IGHG) or membrane cofactor protein MCP
81. An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance